LETTER TO THE EDITOR

Erythrocyte sodium-lithium countertransport in African American women
We read with interest the article by Sherif et al 1 linking sodiumlithium countertransport and left ventricular mass in African American women. However, the authors have overlooked certain characteristics of the countertransporter and this is likely to have affected interpretation of their findings.
First, Sherif et al 1 state that in the literature they cite the maximal rate of turnover (V max ) of the countertransporter was reported. In fact, in all cases cited, the parameter actually determined was sodium-lithium countertransport (SLC) activity. In contrast to the biochemical constant V max , SLC activity is simply a lithium efflux rate determined under highly specific conditions. 2 Although SLC activity is associated with V max , its expression is dependent on different influences. SLC characterisation based on kinetic analysis so as to derive an enzymatic rate constant V max and an external affinity constant (k m ) was introduced to resolve the impact of differing influences on the countertransporter. 2, 3 We presume that Sherif et al 1 accept the marked difference between these two methods of characterisation as they have adopted a kinetic approach to characterisation rather than using the simpler method for determining SLC activity.
Second, by using sodium concentrations above 150 mM, Clearly, values of V max and k m may be determined in some individual cases with substrate concentrations either wholly above or below the true k m and inevitably, some estimates may be unreliable. However, the inter-and intraassay variations for both V max (10 ± 6/6 ± 4%) and k m (11 ± 6/10 ± 5%) are such as to justify the assay being reproducible. 6, 7 No such data are presented by Sherif et al
The two kinetic parameters, V max and k m , appear to represent distinct characteristics of the countertransporter operating under differing putative environmental and genetic influences. 2 In hypertension and coronary artery disease, k m is reduced reflecting a higher affinity for external sodium. 2, 6 In diabetes, k m is reduced in nephropathy; as is V max . In contrast, chronic diabetic subjects without nephropathy show an elevated V max .
2 Surprisingly, Sherif et al 1 report no data for k m , despite having determined V max in a cohort that includes hypertensive subjects. Deriving this parameter may have reinforced the evidence supporting the potential for the countertransporter as a marker.
Finally, in the ethnic population selected for study by Sherif et al, the characteristics of the countertransporter are markedly different from those seen in previous studies, reporting values for V max appear high for a black cohort. 7 Interpretation is also complicated by recruiting a heterogeneous cohort of normotensive and borderline hypertensive pre-menopausal women. Despite inclusion of these potentially confounding variables Sherif 
